Navigation Links
Rodobo International, Inc. Files Fiscal Year 2008 SEC Form 10-K
Date:1/13/2009

Operating expenses for the fiscal year ended September 30, 2008 were $5.1 million, an increase of $1.5 million or 41.7% compared to the fiscal year ended September 30, 2007. However, operating expenses as a percentage of net sales dropped from 28.1% in 2007 to 23.1% in 2008. The increase in operating expenses was mainly due to an increase of $1.0 million in distributor rebates, as a result of sales growth and market expansion.

Net income from the operations was $5.5 million, or $3.80 per basic and diluted share, in the fiscal year ended September 30, 2008, up 111.5% from $2.6 million or $2.69 per basic and diluted share, in the fiscal year ended September 30, 2007. It was mainly attributable to the increase in sales, partially offset by increase in cost of goods sold and operating expenses. Comprehensive income was $6.2 million in the fiscal year ended September 30, 2008, up 129.6% from $2.7 million in the fiscal year ended September 30, 2007.

About Rodobo International, Inc.:

Through its wholly-owned operating subsidiary, Rodobo International, Inc. is a producer and distributor of high-quality formula milk powder products for infants, children, pregnant women, nursing mothers and other adults in the People's Republic of China. The Company's products are sold under brand name "Rodobo".

Safe Harbor Statement

This press release contains forward-looking statements. Whenever we use words such as "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions, we are making forward-looking statements. Forward- looking statements include statements regarding our goals, beliefs, future growth strategies, objectives, plans or current expectations. For example, when we say that we will continue to leverage our superior quality control and further strengthen our market position as consumers seek out quality products in the wake of the recent wide-spread me
'/>"/>

SOURCE Rodobo International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
2. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
5. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
6. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
7. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
10. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
11. Natural Alternatives International, Inc. Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... anti-cancer drugs to the "power plants" that make energy ... approach to preventing emergence of the drug-resistant forms of ... are reporting. That,s the conclusion of a new study ... , Shana Kelley and colleagues explain that doxorubicin ... the genes inside the nucleus of cancer cells. Cancer ...
(Date:5/22/2013)... 22, 2013 Digital Advertising Agency, ... of its social media management client, Primal Pit ... supply of the all-natural organic deodorant. The contest is ... the rapidly-growing start-up deodorant company based in Tampa, Florida. ... or sweepstakes on a Facebook page is a great ...
(Date:5/22/2013)... With the health of a growing fetus largely dependent on ... many women become hyperaware of everything that goes into their ... a pregnancy test. At no other time in life is ... caffeine, alcohol, and nicotine) stronger than during pregnancy. But how ... this increased awareness during pregnancy extend to the lotions, potions, ...
(Date:5/22/2013)... Garcinia cambogia select is a dual action ... the extra fat being stored in the body. For a ... This fat burner helps people in this regard by making ... Basically it does this by secreting a hormone serotonin which ... away from emotional overeating. In this way, it keeps a ...
(Date:5/22/2013)... NJ and Los Angeles, CA (PRWEB) May 22, 2013 ... of the board, The J. M. Smucker Company, and ... Lifetime Achievement Awards yesterday at the GS1 General Assembly ... Angeles, California. Mr. Smucker and Mr. Wegman were recognized ... of GS1 Standards - the most broadly used supply ...
Breaking Medicine News(10 mins):Health News:Social Media Management Firm, 21Digital, Launches National Facebook Sweepstakes for Client, Primal Pit Paste 2Health News:Fairhaven Health Launches New PregnancyPlus Natural Deodorant Designed Specifically for Pregnant Women 2Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3
... STOCKHOLM, March 25 Dr. Bindeshwar Pathak, founder of,Sulabh ... Stockholm Water,Prize Laureate. , To ... , As the Founder of ... around the world for his wide ranging work in ...
... PARSIPPANY, N.J., March 25 It,s a different era ... of an ever-changing industry while battling an uncertain economy. ... the key to retaining market share and maintaining hard-earned ... tools of pharmaceutical competitive intelligence. , ...
... Bulls Legend BJ Armstrong Rallies Students to Get Fit By ... Grant CHICAGO, March 25 Chicago Bulls legend BJ ... fitness game as part of a new national campaign called ... of a new partnership between the "got milk?" Body By Milk(R) ...
... thickness, study finds , , WEDNESDAY, March 25 (HealthDay News) -- ... be associated with a higher risk for depression, U.S. researchers ... 54, including those who did and did not have a ... depression in their family history had a 28 percent thinning ...
... Solution Offers Proactive Monitoring of Critical Systems to ... Patient Care EnhancementNEW YORK, March 25 CareTech ... and services provider for hospitals and health systems, ... desk solution across all hospitals that together comprise ...
... --Company Now Has Until October 26, 2009 to Regain Compliance ... 25 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today ... provides Peregrine with an additional three months to ... now has until October 26, 2009 to regain compliance with ...
Cached Medicine News:Health News:Indian Sanitation Innovator and Social Reformer Awarded 2009 Stockholm Water Prize 2Health News:Support at Fever Pitch for Dynamic, Fresh Approach to Pharmaceutical Competitive Intelligence 2Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 2Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 3Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 4Health News:Got Milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Cesar E. Chavez Multicultural Center 5Health News:Brain 'Thinning' May Indicate Susceptibility to Depression 2Health News:CareTech Solutions Launches Robust Service Desk Solution to Support Clinical Applications and Technology within Continuum Health Partners Hospitals 2Health News:CareTech Solutions Launches Robust Service Desk Solution to Support Clinical Applications and Technology within Continuum Health Partners Hospitals 3Health News:Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2
(Date:5/22/2013)... May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... overview of the company at the following conferences. ... Presentation date: Wednesday May 29, 2013 , Presentation time: ... Healthcare Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of ...
(Date:5/22/2013)... PHILADELPHIA , 22. Mai 2013 /PRNewswire/ ... Sitz in Barcelona , ... aufzeigt, dass eine höhere Dosis von PROLASTIN©-C ... Patienten mit Alpha1-Antitrypsinmangel (AAT) auf ein Niveau ... normal bezeichneten Bereichs liegt. ATT-Mangel ist eine ...
(Date:5/22/2013)...  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical company ... medical needs, today announced the appointment of ... Board of Directors. Dr. Almenoff has extensive experience in ... drug development. "We are delighted to ... Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous expertise ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... PXS) today announced significant results of pooled data from ... of Bronchitol (inhaled mannitol) in people with cystic fibrosis. ... the first time at the North American Cystic Fibrosis ... results from the second trial (CF302) have been released ...
... Oct. 22 INVO Bioscience, Inc. (OTC Bulltin Board: ... for patients diagnosed with infertility, today announced that Dr. ... (CECOFLES LTDA) will present the results of the first ... INVO Bioscience,s INVOcell technology at the 66th Annual Meeting ...
Cached Medicine Technology:Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 2Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 3Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 4Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results 5INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine 2INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine 3
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,408-9) or contact custom...
Medicine Products: